Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children

Pediatric Research

Volumn 51, Issue 2, 2002, Pages 159-168

  Noordzij, Jeroen G ^a   De Bruin Versteeg, Sandra ^a   Marieke Comans Bitter, W ^a   Hartwig, Nico G ^a   Hendriks, Rudolf W ^a   De Groot, Ronald ^a   Van Dongen, Jacques J M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN MU CHAIN; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; STEM CELL; STOP CODON; X LINKED AGAMMAGLOBULINEMIA;

EID: 0036152373     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200202000-00007     Document Type: Article

References (53)

1. X-linked agammaglobulinemia: A disease of BTK tyrosine kinase
2. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 Unique mutations without correlation to clinical course
3. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases
4. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
5. Mutations of the human BTK gene coding for Bruton tyrosine kinase in X-linked agammaglobulinemia
6. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): The use of protein analysis as a diagnostic indicator of XLA
7. Discordant phenotype in siblings with X-linked agammaglobulinemia
8. Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family
9. B lymphocyte precursors in bone-marrow in immunoglobulin deficiency diseases
10. B lymphocyte precursors in human bone marrow: An analysis of normal individuals and patients with antibody-deficiency states
11. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia
12. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype
13. Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients
14. Mutations of the Btk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan
15. Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway
16. B cells in patients with X-linked agammaglobulinemia
17. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia
18. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development
19. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci
20. Multiparameter phenotype mapping of normal and postchemotherapy B lymphopoiesis in pediatric bone marrow
21. B-cell development: A comparison between mouse and man
22. Flow cytometric analysis of normal B cell differentiation: A frame of reference for the detection of minimal residual disease in precursor-B-ALL
23. Btk function in B cell development and response
24. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes
25. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes: Testing of a new fixationpermeabilization solution
26. Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques
27. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
28. Splicing of the platelet-derived growth factor A-chain mRNA in human malignant mesothelioma cell lines and regulation of its expression
29. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
30. Sixty-nine kilobases of contiguous human genomic sequence containing the alpha-galactosidase A and Bruton's tyrosine kinase loci
31. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes
32. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage
33. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases
34. Surface membrane CD22 expression in precursor B-cells
35. Immunoglobulin concentrations in sera of normal children: Quantitation against an international reference preparation
36. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia
37. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: Identification of a mutation which affects the same codon as is altered in immunodeficient xid mice
38. Structural basis for chromosome X-linked agammaglobulinemia: A tyrosine kinase disease
39. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia
40. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA)
41. Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot
42. Flow cytometric diagnosis of the cell lineage and developmental stage of acute lymphoblastic leukemia by novel monoclonal antibodies specific to human pre-B-cell receptor
43. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells
44. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia
45. Mutations in the human λ5/14.1 gene result in B cell deficiency and agammaglobulinemia
46. Mutations in Igα (CD79a) result in a complete block in B-cell development
47. An essential role for BLNK in human B cell development
48. BLNK: Connecting Syk and Btk to calcium signals
49. Early B cell defects
50. The CBA/N mouse strain: An experimental model illustrating the influence of the X-chromosome on immunity
51. Defective B cell development and function in Btk-deficient mice
52. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage
53. - cells with both lymphoid and myeloid potential